Microarray needles comprised of arginine-modified chitosan/PVA hydrogel for enhanced antibacterial and wound healing potential of curcumin

Comparing the effectiveness of curcumin and papain in wound dresses based on chitosan nanoparticle

In this study, chitosan/curcumin (CS/Cur) and chitosan/papain (CS/Pa) nanoparticles were prepared and then characterized by Fourier transform infrared (FTIR), X-ray diffraction (XRD), and differential light scattering (DLS). Subsequently, release rate, porosity, swelling, degradability, anti-inflammatory, antioxidant, antibacterial, and cell viability tests were conducted to investigate and compare the healing potential of the nanoparticles for various types of wounds. The results of FTIR, XRD, and DLS indicated that the nanoparticles were manufactured correctly with a hydrodynamic diameter of 429 nm (CS/Cur) and 460 nm (CS/Pa), and zeta potential of 4.32 mV (CS/Cur) and 7.57 mV (CS/Pa). The release rate results indicated a higher release rate in a basic environment (pH 8.4) for curcumin, a higher release rate for papain in an acidic environment (pH 6.4), and the Korsmeyer-Peppas model for the release of curcumin and papain. The results indicated that CS/Cur with 41.6% antioxidant activity, high antibacterial effect, and cell growth up to 616% during 7 days, was more effective than CS/Pa. In comparison, CS/Pa (with a porosity of 70.5% and a swelling rate of 1392%) was more advantageous than CS/Cur in terms of porosity and swelling. In addition, CS/Cur was as effective as CS/Pa in terms of degradation and anti-inflammatory properties. In conclusion, the outcomes represented that the CS/Cur and CS/Pa nanoparticles improved wound healing, and each was suitable for specific wounds and wound healing stages.

Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals

Phytochemicals, which are predominantly found in plants, hold substantial medicinal value. Despite their potential, challenges such as poor oral bioavailability and instability in the gastrointestinal tract have limited their therapeutic use. Traditional intra/transdermal drug delivery systems offer some advantages over oral administration but still suffer from issues such as limited penetration depth, slow drug release rates, and inconsistent drug absorption. In contrast, microneedles (MNs) represent a significant advancement in intra/transdermal drug delivery by providing precise control over phytochemical delivery and enhanced penetration capabilities. By circumventing skin barriers, MNs directly access dermal layers rich in blood vessels and lymphatics, thus facilitating efficient phytochemical delivery. This review extensively discusses the obstacles of traditional oral delivery and the benefits of intra/transdermal delivery routes with a particular focus on the transformative potential of MNs for phytochemical delivery. This review explores the complexities of delivering phytochemicals through intra/transdermal routes, the development and types of MNs as innovative delivery tools, and the optimal design and properties of MNs for effective phytochemical delivery. Additionally, this review examines the versatile applications of MN-mediated phytochemical delivery, including its role in administering phytophotosensitizers for photodynamic therapy, and concludes with insights into relevant patents and future perspectives.

Research Progress of Hydrogel Microneedles in Wound Management

Microneedles are a novel drug delivery system that offers advantages such as safety, painlessness, minimally invasive administration, simplicity of use, and controllable drug delivery. As a type of polymer microneedle with a three-dimensional network structure, hydrogel microneedles (HMNs) possess excellent biocompatibility and biodegradability and encapsulate various therapeutic drugs while maintaining drug activity, thus attracting significant attention. Recently, they have been widely employed to promote wound healing and have demonstrated favorable therapeutic effects. Although there are reviews about HMNs, few of them focus on wound management. Herein, we present a comprehensive overview of the design and preparation methods of HMNs, with a particular emphasis on their application status in wound healing, including acute wound healing, infected wound healing, diabetic wound healing, and scarless wound healing. Finally, we examine the advantages and limitations of HMNs in wound management and provide suggestions for future research directions.

CDI crosslinked chitosan/poly (vinyl alcohol) electrospun nanofibers loaded with Achillea millefolium and Viola extract: A promising wound dressing

Biopolymer-based electrospun mats, mimicking the extracellular matrix, have been extensively explored in biomedical applications. This study compares Achillea millefolium (AM) and Viola (V) extracts for developing a biocompatible wound dressing. The extracts were incorporated into a Chitosan/polyvinyl alcohol (CS/PVA) matrix via electrospinning. Crosslinking with Carbonyldiimidazole (CDI) improved chemical stability, water resistance, and biodegradability. The resulting mats exhibited flawless interconnected nanofibers, confirming the presence of AM and Viola extracts as analyzed via FTIR. Significant differences were observed between these two herbal extracts, particularly in mechanical properties, with tensile strengths of 6.9 MPa for AM and 17.2 MPa for Viola. Viola extract demonstrated robust antibacterial properties, producing an 8.2 mm inhibition zone against Staphylococcus aureus, compared to AM's 30 %. The release of therapeutic agents indicated an initial rapid phase, followed by a controlled 72 h release at a consistent rate. Notably, Viola extract led to 80.9 % wound closure on the 10th day, surpassing AM extract at 63.7 %. In contrast, the control group achieved only 32.1 % closure. This comparative study underscores the distinct advantages of AM and Viola extracts in wound dressing applications. While AM presents specific strengths, Viola extract exhibits superior mechanical properties, antibacterial efficacy, and accelerated wound closure, suggesting its potential with significant clinical implications.

Industrializable approach for preparing hydrogel microneedles and their application in melanoma treatment

Microneedles (MNs) technology has been studied in transdermal drug delivery for more than 20 years with hundreds of clinical trials conducted. However, there are currently no commercially available MNs in medicine due to challenges in materials safety, cost-effective fabrication, and large-scale manufacturing. Herein, an approach for rapid and green fabrication of hydrogel microneedles (HMNs) based on infrared irradiation process was proposed for the first time. The optimized formulation consisted of polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP), which acted as cross-linked materials and pore-forming agents, respectively. The manufacturing method involved placing MNs patches under infrared irradiation at 70 °C for 2 min and annealing to obtain HMNs with excellent swelling behavior, mechanical strength, and biocompatibility. When model drugs azelaic acid (AZA) and matrine (MAT) were loaded into HMNs systems, the chemical stability of MAT was significantly improved. Ex vivo transdermal delivery experiments indicated that HMNs could achieve synchronous release of AZA and MAT, and the 24-hour percutaneous permeability rates of both drugs were 73.09 ± 0.48 % and 71.56 ± 1.23 %, respectively. In-vivo pharmacokinetic studies, HMNs administration presented dose-dependent stable blood drug concentrations for both drugs. Additionally, prominent anti-tumor efficacy and biosecurity were observed in the drug-loaded HMNs group in the pharmacodynamic evaluation. In summary, the efficient, convenient, and low-cost fabrication method based on infrared irradiation offers the possibility of mass production of drug-loaded HMNs, showing potential for industrial manufacturing development.